Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol

OBJECTIVES: To report the prevalence of, and evaluate risk factors for, the development of hypertriglyceridemia (defined as a serum triglyceride level of > 400 mg/dL) in patients with coronavirus disease 2019 who received propofol. DESIGN: Single-center, retrospective, observational analysis. SET...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovacevic, Mary P., Dube, Kevin M., Lupi, Kenneth E., Szumita, Paul M., DeGrado, Jeremy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808527/
https://www.ncbi.nlm.nih.gov/pubmed/33490957
http://dx.doi.org/10.1097/CCE.0000000000000330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808527/
https://www.ncbi.nlm.nih.gov/pubmed/33490957
http://dx.doi.org/10.1097/CCE.0000000000000330

Ejemplares similares